385 related articles for article (PubMed ID: 8640326)
1. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Velasquez MT
Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
Triggle DJ
Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
[TBL] [Abstract][Full Text] [Related]
4. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.
Burrell LM; Johnston CI
Drugs Aging; 1997 Jun; 10(6):421-34. PubMed ID: 9205848
[TBL] [Abstract][Full Text] [Related]
6. [Angiotensin-II receptor blockers].
Metelitsa VI
Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
[No Abstract] [Full Text] [Related]
7. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
Eberhardt RT; Kevak RM; Kang PM; Frishman WH
J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
[TBL] [Abstract][Full Text] [Related]
8. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
Goa KL; Wagstaff AJ
Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
[TBL] [Abstract][Full Text] [Related]
10. Rationale for the chemical development of angiotensin II receptor antagonists.
Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
[TBL] [Abstract][Full Text] [Related]
11. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
Burrell LM
Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin II antagonists: a distinct therapeutic class].
Waeber B; Brunner HR
Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
Ruff D; Gazdick LP; Berman R; Goldberg AI; Sweet CS
J Hypertens; 1996 Feb; 14(2):263-70. PubMed ID: 8728306
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
15. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
[TBL] [Abstract][Full Text] [Related]
16. Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.
Gillis JC; Markham A
Drugs; 1997 Dec; 54(6):885-902. PubMed ID: 9421695
[TBL] [Abstract][Full Text] [Related]
17. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.
Tomiyama H; Kushiro T; Abeta H; Ishii T; Takahashi A; Furukawa L; Asagami T; Hino T; Saito F; Otsuka Y
Hypertension; 1994 Apr; 23(4):450-5. PubMed ID: 8144214
[TBL] [Abstract][Full Text] [Related]
18. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
Ellis ML; Patterson JH
Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonists: the prototype losartan.
Schaefer KL; Porter JA
Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
Olins GM; Smits GJ; Koepke JP; Huang HC; Reitz DB; Manning RE; Blaine EH
Am J Hypertens; 1993 Jul; 6(7 Pt 1):619-25. PubMed ID: 8398003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
